HR. 5160Introduced
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Extend federal authorization for stem cell therapeutic and research programs through a new reauthorization period
Plain-English overview
What this bill does
Extend federal authorization for stem cell therapeutic and research programs through a new reauthorization period
Key points
- Extend stem cell research programs
Current status
Where it stands
Status
Introduced
Latest action
2026-07-02 — Placed on the Union Calendar, Calendar No. 629.
Related context
Topics and policy areas
undefinedBiological and life sciencesBlood and blood diseasesCell biology and embryologyHealthHealth programs administration and fundingOrgan and tissue donation and transplantation